BMC medicineMetforminHumansAnimalsSodium-Glucose Transporter 2 InhibitorsMale
Urea cycle modulation by combined SGLT2 inhibitors and metformin.
Makoto Harada, Jonathan Adam, Siyu Han, Mengya Shi, Jianhong Ge, Jutta Lintelmann, Alexander Cecil, Sven Zukunft, Cornelia Prehn, Michael Witting, Markus F Scheerer, Susanne Neschen, Martin Irmler, Johannes Beckers, Jerzy Adamski
Published: 202610.1186/s12916-025-04609-7
Abstract
BACKGROUND: Sodium-glucose co-transporter 2 inhibitors (SGLT2i), when combined with metformin (COMBI), offer multi-organ protective effects in patients with type 2 diabetes (T2D), particularly those at high risk of cardiovascular or renal complicatio…
Preview only. Read the full abstract at the source